Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy

Acute promyelocytic leukemia (APL) is a rare and aggressive form of acute myeloid leukemia (AML). Instead of cytotoxic chemotherapy, a combination of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) represents front-line therapy in low-risk patients. However, the therapeutic approach could...

全面介紹

書目詳細資料

Principais autores:	Giorgio Rosati, Sofia Camerlo, Matteo Dalmazzo, Melissa Padrini, Tiziano Tommaso Busana, Marco De Gobbi, Alessandro Fornari, Alessandro Morotti
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2023-07-01
叢編:	Hematology Reports
主題:	Brugada syndrome acute promyelocytic leukemia arsenic all-trans-retinoic acid sudden death
在線閱讀:	https://www.mdpi.com/2038-8330/15/3/45
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!